Evidence map›Paper›PMID 27137910›Full record

ArticleStem cell research & therapy2016

Relevance of HCN2-expressing human mesenchymal stem cells for the generation of biological pacemakers.

Ieva Bruzauskaite, Daiva Bironaite, Edvardas Bagdonas, Vytenis Arvydas Skeberdis, Jaroslav Denkovskij, Tomas Tamulevicius, Valentinas Uvarovas, Eiva Bernotiene

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Probability that there is a mammalian counterpart of cardiac clock in insects.Archives of insect biochemistry and physiology · 2022
    Review
  3. Article
  4. In vitro differentiation of W8B2Cellular & molecular biology letters · 2020
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ieva BruzauskaiteDepartment of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Daiva BironaiteDepartment of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania. daibironai@gmail.com.
Edvardas BagdonasDepartment of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Vytenis Arvydas SkeberdisInstitute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Jaroslav DenkovskijDepartment of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Tomas TamuleviciusInstitute of Materials Science, Kaunas University of Technology, Kaunas, Lithuania.
Valentinas UvarovasClinic of Rheumatology, Orthopedic and Traumatology and Reconstructive Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Eiva BernotieneDepartment of Regenerative Medicine, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
State Research Institute Centre for Innovative Medicine · LTKaunas University of Technology · LTLithuanian University of Health Sciences · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe transfection of human mesenchymal stem cells (hMSCs) with the hyperpolarization-activated cyclic nucleotide-gated ion channel 2 (HCN2) gene has been demonstrated to provide biological pacing in dogs with complete heart block. The mechanism appears to be the generation of the ion current (If) by the HCN2-expressing hMSCs. However, it is not clear how the transfection process and/or the HCN2 gene affect the growth functions of the hMSCs. Therefore, we investigated survival, proliferation, cell cycle, and growth on a Kapton® scaffold of HCN2-expressing hMSCs.

methodshMSCs were isolated from the bone marrow of healthy volunteers applying a selective cell adhesion procedure and were identified by their expression of specific surface markers. Cells from passages 2-3 were transfected by electroporation using commercial transfection kits and a pIRES2-EGFP vector carrying the pacemaker gene, mouse HCN2 (mHCN2). Transfection efficiency was confirmed by enhanced green fluorescent protein (EGFP) fluorescence, quantitative real-time polymerase chain reaction (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA). After hMSCs were transfected, their viability, proliferation, If generation, apoptosis, cell cycle, and expression of transcription factors were measured and compared with non-transfected cells and cells transfected with pIRES2-EGFP vector alone.

resultsIntracellular mHCN2 expression after transfection increased from 22.14 to 62.66 ng/mg protein (p < 0.05). Transfection efficiency was 45 ± 5 %. The viability of mHCN2-transfected cells was 82 ± 5 %; they grew stably for more than 3 weeks and induced If current. mHCN2-transfected cells had low mitotic activity (10.4 ± 1.24 % in G2/M and 83.6 ± 2.5 % in G1 phases) as compared with non-transfected cells (52-53 % in G2/M and 31-35 % in G1 phases). Transfected cells showed increased activation of nine cell cycle-regulating transcription factors: the most prominent upregulation was of AMP-dependent transcription factor ATF3 (7.11-fold, p = 0.00056) which regulates the G1 phase. mHCN2-expressing hMSCs were attached and made anchorage-dependent connection with other cells without transmigration through a 12.7-μm thick Kapton® HN film with micromachined 1-3 μm diameter pores.

conclusionsmHCN2-expressing hMSCs preserved the major cell functions required for the generation of biological pacemakers: high viability, functional activity, but low proliferation rate through the arrest of cell cycle in the G1 phase. mHCN2-expressing hMSCs attached and grew on a Kapton® scaffold without transmigration, confirming the relevance of these cells for the generation of biological pacemakers.

Indexed as

AnimalsBiological ClocksBone Marrow CellsCell AdhesionCell Cycle ProteinsCell ProliferationCell SurvivalElectroporationG1 PhaseGene ExpressionGenes, ReporterGenetic VectorsGreen Fluorescent ProteinsHumansHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsMesenchymal Stem CellsCell Cycle Proteinsenhanced green fluorescent proteinGreen Fluorescent ProteinsHcn2 protein, mouseHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsPotassium ChannelsTranscription FactorsBiological pacemakerHCN2ScaffoldStem cellsTissue regeneration

Identifiers

PMID27137910
PMCPMC4853868
OpenAlexW2344735986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.